Sashwat Pharmaceuticals

Manufacturing of pharmaceutical products, including tablets and syrups, in India.

About Sashwat Pharmaceuticals

Sashwat Pharmaceuticals is a Healthcare company. Manufacturing of pharmaceutical products, including tablets and syrups, in India. Its Indian entity Sashwat Pharmaceuticals Private Limited reported revenue of β‚Ή19.2 Lakh. Sashwat Pharmaceuticals offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Veterinary.

Company details

Sashwat Pharmaceuticals is recognized as a WHO-GMP certified entity that produces a variety of pharmaceutical products such as tablets, capsules, syrups, and veterinary items, with facilities located in Ahmedabad and Vadodara, Gujarat, India. Quality control and production adhere to international standards like ISO 9001:2015, while a wide marketing network ensures distribution across the country. Research and development efforts are maintained to support contract manufacturing, emphasizing compliance and innovation in the pharmaceutical sector. Overall, operations span more than 25 years, focusing on affordability and systematic quality assurance.

Key Metrics
  • Indian entity revenue
    ₹19.2 Lakh

    FY 2025 · -82% YoY

  • Indian entity net loss
    -₹15.6 Lakh

    FY 2025 · -81% margin

  • Indian entity EBITDA
    -₹15.6 Lakh

    FY 2025 · -81% margin

Products & Services of Sashwat Pharmaceuticals

Sashwat Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceutical Products

Tablets are manufactured for various medicinal purposes

Capsules
Pharmaceutical Products

Capsules are produced as part of drug formulations

Board of directors of Sashwat Pharmaceuticals Private Limited (Sashwat Pharmaceuticals)

Sashwat Pharmaceuticals Private Limited is the primary company behind Sashwat Pharmaceuticals. The board of Sashwat Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Pretee Verma, appointed in 2015.

DirectorDesignationAppointedTenureEntity
Pretee Verma
DIN 07242913
Director11 Aug 201511 yrs 2 moSashwat Pharmaceuticals Private Limited
Kedar Verma Nath
DIN 07242890
Director11 Aug 201511 yrs 2 moSashwat Pharmaceuticals Private Limited

Financials of Sashwat Pharmaceuticals

Figures of Sashwat Pharmaceuticals Private Limited, the primary company behind Sashwat Pharmaceuticals, for FY 2025. Revenue was ₹19.2 Lakh (-82% year on year). Net loss was -₹15.6 Lakh (-81% margin). EBITDA was -₹15.6 Lakh (-81% margin). Revenue has grown at a compounded annual rate of -21% over five years.

  • ₹19.2 LakhRevenue · FY 2025 · -82% YoY
  • -₹15.6 LakhNet loss · -81% margin
  • -₹15.6 LakhEBITDA · -81% margin
  • ₹1 LakhPaid-up capital
  • -21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sashwat Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Sashwat Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sashwat Pharmaceuticals

The primary company behind Sashwat Pharmaceuticals, Sashwat Pharmaceuticals Private Limited, reported revenue of β‚Ή19.2 Lakh for FY 2025, down 82% year on year.

Sashwat Pharmaceuticals is recognized as a WHO-GMP certified entity that produces a variety of pharmaceutical products such as tablets, capsules, syrups, and veterinary items, with facilities located in Ahmedabad and Vadodara, Gujarat, India. Quality control and production adhere to international standards like ISO 9001:2015, while a wide marketing network ensures distribution across the country. Research and development efforts are maintained to support contract manufacturing, emphasizing compliance and innovation in the pharmaceutical sector. Overall, operations span more than 25 years, focusing on affordability and systematic quality assurance.

Sashwat Pharmaceuticals offers Tablets and Capsules.

Sashwat Pharmaceuticals operates through Sashwat Pharmaceuticals Private Limited.

The legal entities of Sashwat Pharmaceuticals currently have 2 directors, including Pretee Verma, Kedar Verma Nath.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available